Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (501-510 of 706) with videos related to

Pageof 71
Sort By:
Atherosclerosis|June 18, 2017
Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid managementG B John Mancini, Milan Gupta, Michelle Tsigoulis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2013
Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cellsCorine Glineur, Barbara Gross, Bernadette Neve, et al.
Schizophrenia Research|December 13, 2016
The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosisLisa A Hahn, Andrew Mackinnon, Debra L Foley, et al.
Public Health Genomics|July 23, 2019
Identifying Perceptions and Preferences of the General Public Concerning Universal Screening of Children for Familial HypercholesterolaemiaFaye L Bowman, Caron M Molster, Karla J Lister, et al.
Journal of Clinical Lipidology|August 19, 2023
Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?Natalie C Ward, Qidi Ying, Dick C Chan, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 25, 2015
A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney diseaseEmilie Mas, Anne Barden, Valerie Burke, et al.
Diabetes Research and Clinical Practice|October 11, 2014
Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudyJason A Harmer, Anthony C Keech, Anne-Sophie Veillard, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2014
Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndromeTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
Atherosclerosis|December 4, 2021
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)Anindita Chakraborty, Jing Pang, Dick C Chan, et al.
Pageof 71

Showing results (501-510 of 706) with videos related to

Sort By:
Pageof 71
Atherosclerosis|June 18, 2017
Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid managementG B John Mancini, Milan Gupta, Michelle Tsigoulis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2013
Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cellsCorine Glineur, Barbara Gross, Bernadette Neve, et al.
Schizophrenia Research|December 13, 2016
The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosisLisa A Hahn, Andrew Mackinnon, Debra L Foley, et al.
Public Health Genomics|July 23, 2019
Identifying Perceptions and Preferences of the General Public Concerning Universal Screening of Children for Familial HypercholesterolaemiaFaye L Bowman, Caron M Molster, Karla J Lister, et al.
Journal of Clinical Lipidology|August 19, 2023
Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?Natalie C Ward, Qidi Ying, Dick C Chan, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 25, 2015
A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney diseaseEmilie Mas, Anne Barden, Valerie Burke, et al.
Diabetes Research and Clinical Practice|October 11, 2014
Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudyJason A Harmer, Anthony C Keech, Anne-Sophie Veillard, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2014
Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndromeTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
Atherosclerosis|December 4, 2021
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)Anindita Chakraborty, Jing Pang, Dick C Chan, et al.
Pageof 71